|
Published by: Kalorama Information
Published: Nov. 1, 1996 - 216 Pages Now 50% off the original sale price of $3,250.
Table of Contents
Chapter One: Executive Summary
Introduction
Size and Growth of the Market
Antianxiety Agents
Antidepressants
Antimanic Agents
Antipsychotic Medications
Attention-Deficit/Hyperactivity Disorder Treatments
Substance-Related Disorders Treatments
Description of Psychotherapeutic Drugs
Antianxiety Agents
Antidepressants
Antimanic Agents
Antipsychotic Medications
Attention-Deficit/Hyperactivity Disorder Treatments
Substance-Related Disorders Treatments
Issues and Trends Affecting the Market
Compliance Issues
Demographic Trends
FDA Policy and Approval Process
Generic Competition/Patent Issues
Influence of News Media Coverage
Marketing Trends
Off-Label Prescribing
Research and Development Trends
Third-Party Reimbursement Issues
Industry Structure and Leading Competitors
The Marketplace
Leading Competitors
The End-User
Anxiety Disorders
Post-traumatic Stress Disorder
Attention-Deficit/Hyperactivity Disorder
Eating Disorders
Mood Disorders
Schizophrenia and Other Psychotic Disorders
Substance-Related Disorders
Scope and Methodology
Chapter Two: Introduction To The Nervous System And Mental Disorders
Introduction to the Brain's Communication System
The Nervous System
Mental Disorders: Overview, Prevalence, and Treatment
Anxiety Disorders
Attention-deficit/hyperactivity disorder
Eating Disorders
Mood Disorders
Schizophrenia and Other Psychotic Disorders
Substance-Related Disorders
Chapter Three: Description Of Psychotropic Drugs
The Marketplace
Overview of Industry Competitors
Existing Drugs Used to Treat Mental Disorders
Antianxiety Agents
Antidepressants
Antimanic Agents
Antipsychotic Medications
Attention-deficit/hyperactivity disorder Treatments
Substance-Related Disorders Treatments
Chapter Four: Issues And Trends
Compliance Issues
Demographic Trends
Onset of Mental Disorders
Prevalence
FDA Policy and Approval Process
Approval Process
Related Costs
Generic Competition/Patent Issues
Influence of News Media Coverage
Marketing Trends
Alliances and Co-Promotion
Focus on New Indications for Existing Drugs
Off-Label Prescribing
Research and Development Trends
Third-Party Reimbursement Issues
Effects of Shifts in Mental Health Coverage
Treatment Costs
Chapter Five: The Market
Methodology
Notes on the Data
Introduction
Size of the Market
Antianxiety Agents
Introduction
Market Analysis
Market Size
Major Competitors
Strategies for the Future
Antidepressants
Introduction
Market Analysis
Market Size
Major Competitors
Strategies for the Future
Antimanic Agents
Introduction
Market Analysis
Market Size
Major Competitors
Strategies for the Future
Antipsychotic Medications
Introduction
Market Analysis
Market Size
Major Competitors
Strategies for the Future
Attention-Deficit/Hyperactivity Disorder Treatments
Introduction
Market Analysis
Market Size
Major Competitors
Substance-Related Disorders Treatments
Introduction
Market Analysis
Market Size
Major Competitors
Strategies for the Future
Chapter Six: The European Market
Factors Influencing the Market
Untreated Patients
Ineffective Treatment
New Drugs
New Indications for Drugs
Research
The Products
Types of Psychotropic Drugs
Issues and Trends
EU Rules on Psychotropic Drugs
Approval and Marketing of New Products in Europe
Recent Controversies
The European Market for Psychotropic Drugs
Definitions
Overview
Antianxiety Drugs
Antidepressants
Antipsychotic Drugs
Chapter Seven: Profiles Of Selected Competitors
Companies Selected for Profiles
Abbott Laboratories
History and Lines of Business
Financial Information
Psychotropic Products
Research and Development
Sales and Marketing
Corporate Strategies
Corporate Analysis
American Home Products Corporation
History and Lines of Business
Financial Information
Psychotropic Products
Research and Development
Corporate Strategies
Corporate Analysis
Bristol-Myers Squibb Company
History and Lines of Business
Financial Information
Psychotherapeutic Products
Research and Development
Sales and Marketing
Corporate Strategies
Corporate Analysis
Ciba-Geigy Limited
History and Lines of Business
Financial Information
Psychotherapeutic Products
Research and Development
Corporate Strategies
Corporate Analysis
Eli Lilly and Company
History and Lines of Business
Financial Information
Psychotherapeutic Products
Research and Development
Sales and Marketing
Corporate Strategies
Corporate Analysis
Johnson & Johnson
History and Lines of Business
Financial Information
Psychotherapeutic Products
Research and Development
Corporate Strategies
Corporate Analysis
Pfizer Inc.
History and Lines of Business
Financial Information
Psychotherapeutic Products
Research and Development
Corporate Strategies
Corporate Analysis
Pharmacia & Upjohn, Inc.
History and Lines of Business
Financial Information
Psychotherapeutic Products
Research and Development
Corporate Strategies
Corporate Analysis
Sandoz Pharmaceutical Corporation
History and Lines of Business
Financial Information
Psychotherapeutic Products
Research and Development
Corporate Strategies
Corporate Analysis
SmithKline Beecham Pharmaceuticals
History and Lines of Business
Financial Information
Psychotherapeutic Products
Research and Development
Corporate Strategies
Corporate Analysis
Appendix: Company Names And Addresses
AbstractThis report from Kalorama Information provides analysis of the dynamic U.S. market for existing and emerging psychotherapeutic drugs. Examines seven primary market segments, anti-anxiety agents, antidepressants, antimanic agents, antipsychotic medications, CNS stimulants, substance-related disorder treatments, and emerging drugs in development. Provides in-depth coverage of historical, current, and forecast market size for each of the categories. Profiles major competitors and emerging industry participants.
Get Full Details About This Report >>
|
